Evogene Ltd (NASDAQ:EVGN)

2.69
Delayed Data
As of Nov 14
 0.00 / 0.00%
Today’s Change
2.50
Today|||52-Week Range
4.20
-12.38%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close2.69
Today’s open2.55
Day’s range2.55 - 2.71
Volume2
Average volume (3 months)6,778
Market cap$69.3M
Data as of 3:32pm ET, 11/14/2018

Growth & Valuation

Earnings growth (last year)-5.19%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-48.30%
P/E ratioNM
Price/Sales25.33
Price/Book1.00

Competitors

 Today’s
change
Today’s
% change
BNGOBioNano Genomics Inc+0.18+2.56%
ALPNAlpine Immune Scienc...+0.12+2.36%
ARAVAravive Inc+0.10+1.69%
ASTAsterias Biotherapeu...-0.04-3.08%
Data as of 8:00pm ET, 11/16/2018

Financials

Next reporting dateFebruary 27, 2019
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$3.4M
Annual profit (last year)-$20.8M
Net profit margin-616.33%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Operating Officer
Yuval Ben-Galim
Corporate headquarters
Rehovot, Hamerkaz

Forecasts

Chart unavailable